1. Home
  2. LWLG vs RCEL Comparison

LWLG vs RCEL Comparison

Compare LWLG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$4.09

Market Cap

578.6M

Sector

Industrials

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.45

Market Cap

114.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWLG
RCEL
Founded
1991
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.6M
114.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LWLG
RCEL
Price
$4.09
$3.45
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.75
AVG Volume (30 Days)
1.2M
192.5K
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$100,605.00
$72,401,000.00
Revenue This Year
N/A
$13.12
Revenue Next Year
N/A
$27.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.59
52 Week Low
$0.79
$3.35
52 Week High
$6.26
$14.16

Technical Indicators

Market Signals
Indicator
LWLG
RCEL
Relative Strength Index (RSI) 42.53 35.22
Support Level $3.78 $3.42
Resistance Level $4.43 $3.68
Average True Range (ATR) 0.33 0.20
MACD -0.05 -0.00
Stochastic Oscillator 30.61 4.41

Price Performance

Historical Comparison
LWLG
RCEL

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: